135 related articles for article (PubMed ID: 9219441)
21. 51 Cr-L-asparagine accumulation by tumors: the influence of L-asparaginase treatment.
Anghileri LJ
J Nucl Biol Med; 1970; 14(4):150-2. PubMed ID: 5538035
[No Abstract] [Full Text] [Related]
22. Antileukemic effect of L-aspartyl-hydrazine.
Stern P; Valjevac K; Balenović K
Neoplasma; 1975; 22(1):69-71. PubMed ID: 1153038
[TBL] [Abstract][Full Text] [Related]
23. Levels of enzymes in leukaemic mice treated withAeromonas L-asparaginase.
Benny PJ; Muraleedhara Kurup G; Sreejith K
Indian J Clin Biochem; 1999 Jul; 14(2):189-97. PubMed ID: 23105218
[TBL] [Abstract][Full Text] [Related]
24. Enzyme therapy of cancer, future studies.
Holcenberg JS
Cancer Treat Rep; 1981; 65 Suppl 4():61-5. PubMed ID: 7346158
[TBL] [Abstract][Full Text] [Related]
25. A general survey of glutamine level in different tissues of murine solid tumor bearing mice before and after therapy with purified glutaminase.
Maity P; Chakraborty S; Bhattacharya P
J Exp Clin Cancer Res; 2000 Jun; 19(2):161-4. PubMed ID: 10965812
[TBL] [Abstract][Full Text] [Related]
26. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
[TBL] [Abstract][Full Text] [Related]
27. Antineoplastic activity of highly purified bacterial glutaminases.
Roberts J; Holcenberg JS; Dolowy WC
Nature; 1970 Sep; 227(5263):1136-7. PubMed ID: 4915990
[No Abstract] [Full Text] [Related]
28. Enzymes of creatine biosynthesis, arginine and methionine metabolism in normal and malignant cells.
Bera S; Wallimann T; Ray S; Ray M
FEBS J; 2008 Dec; 275(23):5899-909. PubMed ID: 19021765
[TBL] [Abstract][Full Text] [Related]
29. Thrombosis associated with L-asparaginase therapy and low fibrinogen levels in adult acute lymphoblastic leukemia.
Beinart G; Damon L
Am J Hematol; 2004 Dec; 77(4):331-5. PubMed ID: 15551293
[TBL] [Abstract][Full Text] [Related]
30. [Progress in researches on anti-tumor agent L-asparaginase for treatment of leukemia].
Zhou J; Jin H; Li Y; Jiang T
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2000 Sep; 17(3):343-5. PubMed ID: 11285852
[TBL] [Abstract][Full Text] [Related]
31. L-asparaginase induced intracranial haemorrhage in acute lymphoblastic leukemia.
Lim HL; Teo CP; Wong K; Kueh YK
Singapore Med J; 1998 Feb; 39(2):76-8. PubMed ID: 9652181
[TBL] [Abstract][Full Text] [Related]
32. L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage.
Top PC; Tissing WJ; Kuiper JW; Pieters R; van Eijck CH
Pediatr Blood Cancer; 2005 Jan; 44(1):95-7. PubMed ID: 15368548
[TBL] [Abstract][Full Text] [Related]
33. Preliminary in vivo evaluation of the protein transduction domain-modified ATTEMPTS approach in enhancing asparaginase therapy.
Li YT; Kwon YM; Spangrude GJ; Liang JF; Chung HS; Park YJ; Yang VC
J Biomed Mater Res A; 2009 Oct; 91(1):209-20. PubMed ID: 18814276
[TBL] [Abstract][Full Text] [Related]
34. Combination therapy of animal tumors with L-asparaginase and antagonists of glutamine or glutamic acid.
Tarnowski GS; Mountain IM; Stock CC
Cancer Res; 1970 Apr; 30(4):1118-22. PubMed ID: 5504351
[No Abstract] [Full Text] [Related]
35. Effect of Vitreoscilla hemoglobin on production of a chemotherapeutic enzyme, L-asparaginase, by Pseudomonas aeruginosa.
Geckil H; Gencer S; Ates B; Ozer U; Uckun M; Yilmaz I
Biotechnol J; 2006 Feb; 1(2):203-8. PubMed ID: 16892249
[TBL] [Abstract][Full Text] [Related]
36. [A new antineoplastic drug: the L-asparaginase. Future possibilities of antitumor enzymotherapy].
Nervi C; Casale C; Cortese M
Policlinico Prat; 1969 Mar; 76(10):297-304. PubMed ID: 5252042
[No Abstract] [Full Text] [Related]
37. Selective apoptosis of natural killer-cell tumours by l-asparaginase.
Ando M; Sugimoto K; Kitoh T; Sasaki M; Mukai K; Ando J; Egashira M; Schuster SM; Oshimi K
Br J Haematol; 2005 Sep; 130(6):860-8. PubMed ID: 16156856
[TBL] [Abstract][Full Text] [Related]
38. [Significance of L-asparaginase activity and biochemical parameters evaluation in children with acute lymphoblastic leukemia].
Pawińska K; Balwierz W; Sztefko K; Czogała M
Przegl Lek; 2006; 63(1):44-6. PubMed ID: 16892900
[TBL] [Abstract][Full Text] [Related]
39. [Temporary effective treatment with L-asparaginase for a patient with refractory nasal NK/T-cell lymphoma].
Sakamoto E; Yamane T; Nakane T; Takeoka Y; Hirose A; Hagihara K; Nakamae H; Ohta K; Hirayama M; Ikura Y; Ohsawa M; Sawada T; Kitoh T; Hino M
Gan To Kagaku Ryoho; 2005 Nov; 32(12):1993-6. PubMed ID: 16282743
[TBL] [Abstract][Full Text] [Related]
40. Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour.
Valadares MC; Ramos AL; Rehmann FJ; Sweeney NJ; Strohfeldt K; Tacke M; Queiroz ML
Eur J Pharmacol; 2006 Mar; 534(1-3):264-70. PubMed ID: 16513106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
